This study is a randomized, double-blind, controlled clinical trial designed to evaluate the impact of non-invasive spinal cord electrical stimulation (tSCS) on the outcome of patients with neuropathic pain.Subjects will be randomized into a test group (treated with tSCS) and a control group (receiving sham stimulation).The intervention period was during the patient's hospitalization, with a follow-up period of 3 months.Patients' pain and quality of life will be assessed at baseline, at the end of the intervention, and during the follow-up period to compare the difference in efficacy between the two groups.
No linked publications found in PubMed
Inclusion Criteria: * Age 18-80 years old; * Meet the diagnostic criteria for neuropathic pain * Chronic low back pain due to neuropathic pain, with or without leg pain; * The skin at the site of irritation is intact; * The patient's vital signs are stable. Exclusion Criteria: * Pain is mainly caused by non-neuropathic factors, such as acute inflammation and trauma; * Those with severe mental illness affecting the study assessment, those with severe cognitive impairment unable to communicate normally or with very poor compliance; * Accompanied by severe cardiac, hepatic, renal and other vital organ insufficiency; * Recently received other related treatments that may affect the impact of neuropathic pain.